Effect of chain length of HAV-VP3 synthetic peptides on its interaction with biomembrane models

Biopolymers. 2000 Dec;54(7):477-88. doi: 10.1002/1097-0282(200012)54:7<477::AID-BIP10>3.0.CO;2-L.

Abstract

Shorter analogues of a continuous epitope of hepatitis A virus, VP3(110-121) peptide, failed to react with convalescent sera, indicating the importance of the entire peptide in the epitope structure. To better understand the influence of the structural properties of this 12-mer peptide epitope on its biological activity, the interaction of smaller peptide analogues with phospholipid biomembrane models was investigated by a combination of spectroscopic and biophysical techniques. In this article we describe our findings concerning the surface activity and the interaction of peptides with simple mono- and bilayer membranes composed of a zwitterionic phospholipid (dipalmitoyl phosphatidylcholine, DPPC), an anionic phospholipid (dipalmitoyl phosphatidylglicerol, DPPG), or a DPPC/DPPG mixture. The results indicate that the net negative charge of the peptide is in some way responsible of the specific interactions between VP3(110-121) and membrane phospholipids, and necessary to induce beta-type conformations upon vesicle interaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Capsid / chemical synthesis
  • Capsid / chemistry*
  • Capsid / metabolism
  • Capsid Proteins*
  • Hepatovirus / chemistry
  • Lipid Bilayers / chemistry
  • Lipid Bilayers / metabolism*
  • Liposomes / chemistry
  • Liposomes / metabolism
  • Peptide Fragments / chemical synthesis
  • Peptide Fragments / chemistry*
  • Peptide Fragments / metabolism
  • Peptides / chemical synthesis
  • Peptides / chemistry*
  • Peptides / metabolism
  • Phospholipids / metabolism
  • Phospholipids / pharmacology
  • Protein Binding
  • Protein Conformation / drug effects
  • Spectrometry, Fluorescence
  • Structure-Activity Relationship

Substances

  • Capsid Proteins
  • Lipid Bilayers
  • Liposomes
  • Peptide Fragments
  • Peptides
  • Phospholipids
  • VP3 peptide (110-121), hepatitis A virus